Fonte: The Journal of Evidence-Based Dental Practice. Unidade: FOB
Assuntos: COVID-19, ANTISSÉPTICOS BUCAIS, DENTIFRÍCIO, SINTOMAS GERAIS
ABNT
POLETI, Marcelo Lupion et al. Use of mouthwash and dentifrice containing an antimicrobial phthalocyanine derivative for the reduction of clinical symptoms of COVID-19: a randomized triple-blind clinical trial. The Journal of Evidence-Based Dental Practice, v. 22, n. 4, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.jebdp.2022.101777. Acesso em: 01 nov. 2024.APA
Poleti, M. L., Gregório, D., Bistaffa, A. G. I., Fernandes, K. B. P., Vilhena, F. V., Santos, P. S. da S., et al. (2022). Use of mouthwash and dentifrice containing an antimicrobial phthalocyanine derivative for the reduction of clinical symptoms of COVID-19: a randomized triple-blind clinical trial. The Journal of Evidence-Based Dental Practice, 22( 4). doi:10.1016/j.jebdp.2022.101777NLM
Poleti ML, Gregório D, Bistaffa AGI, Fernandes KBP, Vilhena FV, Santos PS da S, Simão ANC, Lozovoy MAB, Tatibana BT, Fernandes TMF. Use of mouthwash and dentifrice containing an antimicrobial phthalocyanine derivative for the reduction of clinical symptoms of COVID-19: a randomized triple-blind clinical trial [Internet]. The Journal of Evidence-Based Dental Practice. 2022 ; 22( 4):[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.jebdp.2022.101777Vancouver
Poleti ML, Gregório D, Bistaffa AGI, Fernandes KBP, Vilhena FV, Santos PS da S, Simão ANC, Lozovoy MAB, Tatibana BT, Fernandes TMF. Use of mouthwash and dentifrice containing an antimicrobial phthalocyanine derivative for the reduction of clinical symptoms of COVID-19: a randomized triple-blind clinical trial [Internet]. The Journal of Evidence-Based Dental Practice. 2022 ; 22( 4):[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.jebdp.2022.101777